Drug groups [BR:br08330]
Cardiovascular agent
DG01502 Endothelin receptor antagonist
D03009 Atrasentan hydrochloride
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D03009 Atrasentan hydrochloride
DG02924 UGT substrate
D03009 Atrasentan hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Endothelin
EDNRA
D03009 Atrasentan hydrochloride (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D03009
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D03009
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D03009